1-7 of 7
Ali Amirkhosravi, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mechanism of Thrombocytopenia Induced by Anti-CD40 Ligand Immune Complexes and the Prevalence of CD40 Ligand Autoantibodies in Patients with Thrombotic Autoimmune Disorders

Ali Amirkhosravi, Ph.D., Todd V Meyer, Ph.D., Liza Robles-Carillo, MS, Monica Davila, Ph.D., Florian Langer, MD, Hina Desai, MS, Patricia Weinstein, RN, Mildred Amaya, MS, Eduardo Reyes, MS, John L Francis, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 2857.
https://doi.org/10.1182/blood.V112.11.2857.2857
Published: 2008
Journal Articles

Bevacizumab Immune Complexes Induce Thrombocytopenia and Thrombosis in Mice Transgenic for Human IgG Receptor FcYIIa

Ali Amirkhosravi, Ph.D., Todd V Meyer, Ph.D., Liza Robles-Carillo, MS, Florian Langer, MD, Theresa Robson, BS, Hina Desai, MS, Monica Davila, Ph.D., Mildred Amaya, MS, John L. Francis, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 114.
https://doi.org/10.1182/blood.V112.11.114.114
Published: 2008
Journal Articles

High-Dose Calcitriol Modulates the Expression and Activity of Tissue Factor and Thrombomodulin in Tumor Cells.

Enriqueta Coll-Sangrona, PhD, Ali Amirkhosravi, Ph.D., Alshad S. Lalani, Ph.D., Liza Robles, M.S., Hina Desai, M.S., Mildred Amaya, M.S., John L. Francis, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 921.
https://doi.org/10.1182/blood.V110.11.921.921
Published: 2007
Journal Articles

Targeting Angiogenesis in Cancer: Bevacizumab-Induced Platelet Activation as a Possible Cause for Unexpected Arterial Thromboembolic Events in Clinical Trials.

Todd Meyer, PhD, Theresa Robson, B.S., Ali Amirkhosravi, Ph.D., Florian Langer, M.D., Hina Desai, M.S., Mildred Amaya, M.S., Pierre Elias, John L. Francis, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1091.
https://doi.org/10.1182/blood.V108.11.1091.1091
Published: 2006
Journal Articles

Platelet Activation by a Humanized Monoclonal CD40 Ligand (CD40L) Antibody.

Todd Meyer, PhD, Ali Amirkhosravi, Ph.D., Theresa Robson, B.A., Mildred Amaya, M.S., Desai Hina, M.S., Lihe Su, Ph.D., Yen-Ming Hsu, Ph.D., Florian Langer, M.D., John L. Francis, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1516.
https://doi.org/10.1182/blood.V108.11.1516.1516
Published: 2006
Journal Articles

Genetic Evidence That CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia.

Susan B. Ingersoll, Ph.D., Ali Amirkhosravi, Ph.D., Florian Langer, M.D., Jamie Walker, Todd Meyer, Ph.D., Mildred Amaya, John L. Francis, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2975.
https://doi.org/10.1182/blood.V104.11.2975.2975
Published: 2004
Journal Articles

Functional Consequences of Cellular Interactions with Heparin-PF4 Antibodies in Heparin-Induced Thrombocytopenia.

Sarfraz Ahmad, Ph.D., Ali Amirkhosravi, Ph.D., Jamie M. Walker, B.S., Hina Desai, M.S., Mildred Amaya, M.S., Farooq A. Siddiqui, Ph.D., John L. Francis, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3498.
https://doi.org/10.1182/blood.V104.11.3498.3498
Published: 2004